Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Poliovirus Type 3 Saukett Strain Capsid Proteins (PV3 Saukett Capsid)
- Target
- PV3 Saukett Capsid
- Molecular classification
- Structural Protein, Viral Capsid Protein
01
Overview
The capsid proteins of the poliovirus type 3 Saukett strain (VP1, VP2, VP3, and VP4) are structural proteins that form the outer shell of the virus particle. These proteins encapsulate and protect the viral RNA genome and play a critical role in host cell recognition, entry, and immune response activation. The Saukett strain is used in the production of inactivated poliovirus vaccine (IPV). The capsid proteins elicit neutralizing antibody responses essential for protective immunity against poliomyelitis.
- Other names
- Poliovirus 3 Saukett CapsidPV-3 Saukett Capsid ProteinsSaukett Poliovirus CapsidVP1, VP2, VP3, VP4 (Poliovirus Type 3 Saukett)
02
Mechanism of action
The inactivated poliovirus vaccine (IPV) contains purified, formaldehyde-inactivated type 3 poliovirus grown from this strain, leading to production of neutralizing antibodies that prevent viral infection.
03
Biological functions
Viral encapsulationHost cell recognitionHost cell entryImmune response activationAntigen presentationGenome protection
04
Disease associations
PoliomyelitisViral infection
05
Safety considerations
Potential for reversion to virulence (in live attenuated vaccines, but not applicable to the inactivated Saukett strain)
06
Interacting drugs
Formaldehyde (inactivated polio vaccine)
1 more in the full profile.
07
Biomarkers
Neutralizing antibody titers against PV3 Saukett
Beyond the preview
Go deeper on Poliovirus Type 3 Saukett Strain Capsid Proteins (PV3 Saukett Capsid).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Poliovirus Type 3 Saukett Strain Capsid Proteins (PV3 Saukett Capsid).